Bertulfo, Renato, JR. B.

HRN: 22-56-33  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/10/2023
AMPICILLIN 250MG (VIAL)
02/10/2023
02/16/2023
IV
120mg
Q6hr
Infection
Waiting Final Action 
02/10/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
02/10/2023
02/16/2023
IV
12mg
Q24hr
Infection
Waiting Final Action 
02/10/2023
CEFTAZIDIME 1GM (VIAL)
02/10/2023
02/16/2023
IVT
120mg
Q12hrs
T/c Neonatal Sepsis
Waiting Final Action 
02/12/2023
CEFOTAXIME 500MG (VIAL)
02/12/2023
02/18/2023
IVT
120mg
Q12
Pcap D
Waiting Final Action 
05/15/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/15/2024
05/22/2024
IV
300 Mg
Q6
URTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: